These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 6333184)

  • 1. Effects of nutrition on disease and life span. I. Immune responses, cardiovascular pathology, and life span in MRL mice.
    Mark DA; Alonso DR; Quimby F; Thaler HT; Kim YT; Fernandes G; Good RA; Weksler ME
    Am J Pathol; 1984 Oct; 117(1):110-24. PubMed ID: 6333184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of nutrition of disease and life span. II. Vascular disease, serum cholesterol, serum thromboxane, and heart-produced prostacyclin in MRL mice.
    Mark DA; Alonso DR; Tack-Goldman K; Thaler HT; Tremoli E; Weksler BB; Weksler ME
    Am J Pathol; 1984 Oct; 117(1):125-30. PubMed ID: 6385725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporine therapy suppresses ocular and lacrimal gland disease in MRL/Mp-lpr/lpr mice.
    Jabs DA; Lee B; Burek CL; Saboori AM; Prendergast RA
    Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):377-83. PubMed ID: 8603842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of lymphoproliferation in MRL-lpr/lpr mice.
    Smathers PA; Santoro TJ; Chused TM; Reeves JP; Steinberg AD
    J Immunol; 1984 Oct; 133(4):1955-61. PubMed ID: 6332142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventive action of carotenoids on the development of lymphadenopathy and proteinuria in MRL-lpr/lpr mice.
    Tomita Y; Jyonouchi H; Engelman RW; Day NK; Good RA
    Autoimmunity; 1993; 16(2):95-102. PubMed ID: 8180322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary fat influences the expression of autoimmune disease in MRL/lpr/lpr mice.
    Morrow WJ; Homsy J; Swanson CA; Ohashi Y; Estes J; Levy JA
    Immunology; 1986 Nov; 59(3):439-43. PubMed ID: 3491785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic determinants of autoimmune disease and coronary vasculitis in the MRL-lpr/lpr mouse model of systemic lupus erythematosus.
    Gu L; Weinreb A; Wang XP; Zack DJ; Qiao JH; Weisbart R; Lusis AJ
    J Immunol; 1998 Dec; 161(12):6999-7006. PubMed ID: 9862736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of autoimmune disease and of massive lymphadenopathy in MRL/Mp-lpr/lpr mice lacking tyrosine kinase Fyn (p59fyn).
    Takahashi T; Yagi T; Kakinuma S; Kurokawa A; Okada T; Takatsu K; Aizawa S; Katagiri T
    J Immunol; 1997 Sep; 159(5):2532-41. PubMed ID: 9278347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host modifier genes affect mouse autoimmunity induced by the lpr gene.
    Wang Y; Nose M; Kamoto T; Nishimura M; Hiai H
    Am J Pathol; 1997 Dec; 151(6):1791-8. PubMed ID: 9403730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of autoimmune disease by green tea in MRL-Faslprcg/Faslprcg mice.
    Sayama K; Oguni I; Tsubura A; Tanaka S; Matsuzawa A
    In Vivo; 2003; 17(6):545-52. PubMed ID: 14758719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intercellular adhesion molecule-1 deficiency protects MRL/MpJ-Fas(lpr) mice from early lethality.
    Bullard DC; King PD; Hicks MJ; Dupont B; Beaudet AL; Elkon KB
    J Immunol; 1997 Aug; 159(4):2058-67. PubMed ID: 9257874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of early and late treatment with anti-CD4 monoclonal antibody on autoimmune disease in MRL/MP-lpr/lpr mice.
    Jabs DA; Kuppers RC; Saboori AM; Burek CL; Enger C; Lee B; Prendergast RA
    Cell Immunol; 1994 Mar; 154(1):66-76. PubMed ID: 7907009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effect of the autoimmune Yaa and lpr genes on the acceleration of lupus-like syndrome in MRL/MpJ mice.
    Merino R; Shibata T; De Kossodo S; Izui S
    Eur J Immunol; 1989 Nov; 19(11):2131-7. PubMed ID: 2599002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An immunomodulating anti-rheumatic drug, lobenzarit disodium (CCA): inhibition of polyclonal B-cell activation and prevention of autoimmune disease in MRL/Mp-lpr/lpr mice.
    Mihara M; Nakano T; Ohsugi Y
    Clin Immunol Immunopathol; 1987 Dec; 45(3):366-74. PubMed ID: 3500002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL/lpr mice.
    Matsumoto K; Watanabe N; Akikusa B; Kurasawa K; Matsumura R; Saito Y; Iwamoto I; Saito T
    Arthritis Rheum; 2003 Feb; 48(2):486-94. PubMed ID: 12571859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crucial dietary factors in maximizing life span and longevity in autoimmune-prone mice.
    Kubo C; Johnson BC; Gajjar A; Good RA
    J Nutr; 1987 Jun; 117(6):1129-35. PubMed ID: 3598724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unique surface phenotype of T cells in lymphoproliferative autoimmune MRL/Mp-lpr/lpr mice.
    Takei F
    J Immunol; 1984 Oct; 133(4):1951-4. PubMed ID: 6332141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An epistatic effect of the female specific loci on the development of autoimmune vasculitis and antinuclear autoantibody in murine lupus.
    Zhang MC; Misu N; Furukawa H; Watanabe Y; Terada M; Komori H; Miyazaki T; Nose M; Ono M
    Ann Rheum Dis; 2006 Apr; 65(4):495-500. PubMed ID: 16150787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marked acceleration of the autoimmune disease in MRL-lpr/lpr mice by the influence of the Yaa gene from BXSB mice.
    Miyawaki S; Nakamura Y; Takeshita T; Yoshida H; Shibata Y; Mitsuoka S
    Lab Anim Sci; 1988 Jun; 38(3):266-72. PubMed ID: 2970562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephritogenicity of the lprcg gene on the MRL background.
    Kimura M; Ogata Y; Shimada K; Wakabayashi T; Onoda H; Katagiri T; Matsuzawa A
    Immunology; 1992 Jul; 76(3):498-504. PubMed ID: 1526655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.